What Is in the Literature.

Area of Science:

• Neurology
• Clinical Medicine
• Neuroscience

Background:

• Motor neuron disease (MND), encompassing amyotrophic lateral sclerosis (ALS) and primary lateral sclerosis (PLS), presents ongoing clinical challenges.
• Effective disease-modifying treatments for ALS remain elusive, with recent drug trials failing to meet retesting standards.

Purpose of the Study:

• To review recent literature on the clinical aspects of MND, focusing on ALS and PLS.
• To synthesize new findings on ALS pathogenesis, biomarkers, and therapeutic strategies.
• To provide updated clinical management guidelines and discuss patient-centered care.

Main Methods:

• Literature review of articles published within the past year.
• Focus on clinical aspects, including treatment efficacy, disease mechanisms, and patient-reported outcomes.
• Synthesis of information on diagnostic challenges in PLS and multidisciplinary care.

Main Results:

• Disease-modifying treatments for ALS continue to be a significant challenge.
• New hypotheses regarding the late-onset development of ALS have been proposed.
• Research has yielded new data on fluid biomarkers, sex differences, medical marijuana efficacy for symptom management, and cognitive dysfunction in ALS.
• Updated guidelines for multidisciplinary management are available.
• Patient perspectives on sexual health, end-of-life care, and quality of life with tracheal ventilation are explored.
• Diagnostic and practical aspects of PLS have been reviewed.

Conclusions:

• ALS treatment remains a complex area with limited disease-modifying options.
• A deeper understanding of ALS pathogenesis may emerge from multistep models.
• Comprehensive, multidisciplinary care and attention to patient quality of life are crucial for managing MND.
• Further research is needed to address diagnostic challenges in PLS and optimize patient care.